Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical) has announced the addition of the "Biopharmaceutical Bioseparation Systems - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 52 companies including many key and niche players such as:
- 3M Company (US)
- 3M Purification, Inc. (US)
- Agilent Technologies, Inc. (US)
- Alfa Wassermann Separation Technologies, LLC (US)
- Flottweg Separation Technology (US)
- GEA Westfalia Separator Group GmbH (Germany)
- GE Healthcare (UK)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- Konik Nanobiotech SL (Spain)
- Merck KGaA (Germany)
- NuSep Holdings Ltd. (Australia)
- Pall Corporation (US)
- ProMetic Life Sciences, Inc. (Canada)
- Sartorius Stedim Biotech (France)
- Spectrum Laboratories, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Tosoh Bioscience, Inc. (Japan)
- YMC Europe GmbH (Germany)
Key Topics Covered:
1. Outlook
2. Industry Overview
3. Bioseparation Technologies - Key Trends
4. Product Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (32)
- Canada (1)
- Japan (5)
- Europe (18)
- - France (3)
- - Germany (9)
- - The United Kingdom (1)
- - Spain (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



